{"frames":[{"target":{"name":"Craft","spans":[{"start":0,"end":1,"text":"Science"}]},"annotationSets":[{"rank":0,"score":11.691366466170551,"frameElements":[]}]},{"target":{"name":"Medical_specialties","spans":[{"start":2,"end":3,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":4.571156479647906,"frameElements":[{"name":"Specialty","spans":[{"start":0,"end":3,"text":"Science translational medicine"}]}]}]}],"tokens":["Science","translational","medicine","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":5,"end":6,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":35.29178407157971,"frameElements":[]}]}],"tokens":["Plasma","AR","and","abiraterone-resistant","prostate","cancer","."]}
{"frames":[{"target":{"name":"Frequency","spans":[{"start":8,"end":9,"text":"rare"}]},"annotationSets":[{"rank":0,"score":30.69044348520151,"frameElements":[{"name":"Event","spans":[{"start":9,"end":12,"text":"in prostate cancer"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":11,"end":12,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":35.05253134472619,"frameElements":[]}]},{"target":{"name":"First_rank","spans":[{"start":13,"end":14,"text":"primary"}]},"annotationSets":[{"rank":0,"score":12.127091689664795,"frameElements":[{"name":"Item","spans":[{"start":14,"end":15,"text":"hormone"}]}]}]},{"target":{"name":"Cure","spans":[{"start":15,"end":16,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":44.64247198691575,"frameElements":[]}]},{"target":{"name":"Departing","spans":[{"start":17,"end":18,"text":"emerge"}]},"annotationSets":[{"rank":0,"score":96.80951366154773,"frameElements":[{"name":"Theme","spans":[{"start":18,"end":21,"text":"with castration resistance"}]}]}]}],"tokens":["Androgen","receptor","-LRB-","AR","-RRB-","gene","aberrations","are","rare","in","prostate","cancer","before","primary","hormone","treatment","but","emerge","with","castration","resistance","."]}
{"frames":[{"target":{"name":"Contingency","spans":[{"start":1,"end":2,"text":"determine"}]},"annotationSets":[{"rank":0,"score":11.35021025087783,"frameElements":[{"name":"Determinant","spans":[{"start":17,"end":18,"text":"we"}]}]}]},{"target":{"name":"Using","spans":[{"start":5,"end":6,"text":"using"}]},"annotationSets":[{"rank":0,"score":96.8440528595936,"frameElements":[{"name":"Instrument","spans":[{"start":6,"end":10,"text":"a minimally invasive assay"}]}]}]},{"target":{"name":"Capability","spans":[{"start":11,"end":12,"text":"could"}]},"annotationSets":[{"rank":0,"score":42.48413823234756,"frameElements":[{"name":"Event","spans":[{"start":12,"end":13,"text":"have"}]},{"name":"Entity","spans":[{"start":10,"end":11,"text":"that"}]}]}]},{"target":{"name":"Being_obligated","spans":[{"start":12,"end":13,"text":"have"}]},"annotationSets":[{"rank":0,"score":19.13859316451493,"frameElements":[]}]},{"target":{"name":"Dimension","spans":[{"start":13,"end":14,"text":"broad"}]},"annotationSets":[{"rank":0,"score":20.337049302999876,"frameElements":[{"name":"Object","spans":[{"start":15,"end":16,"text":"utility"}]},{"name":"Dimension","spans":[{"start":13,"end":14,"text":"broad"}]}]}]},{"target":{"name":"Usefulness","spans":[{"start":15,"end":16,"text":"utility"}]},"annotationSets":[{"rank":0,"score":21.456924966582093,"frameElements":[{"name":"Entity","spans":[{"start":14,"end":15,"text":"clinical"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":18,"end":19,"text":"developed"}]},"annotationSets":[{"rank":0,"score":87.64554988700472,"frameElements":[{"name":"Agent","spans":[{"start":17,"end":18,"text":"we"}]},{"name":"Project","spans":[{"start":19,"end":28,"text":"a targeted next-generation sequencing approach amenable to plasma DNA"}]}]}]},{"target":{"name":"Purpose","spans":[{"start":20,"end":21,"text":"targeted"}]},"annotationSets":[{"rank":0,"score":29.635489746760637,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":23,"end":24,"text":"approach"}]},"annotationSets":[{"rank":0,"score":22.81074278710215,"frameElements":[{"name":"Means","spans":[{"start":23,"end":28,"text":"approach amenable to plasma DNA"}]}]}]},{"target":{"name":"Topic","spans":[{"start":29,"end":30,"text":"covering"}]},"annotationSets":[{"rank":0,"score":29.05080430301302,"frameElements":[{"name":"Topic","spans":[{"start":30,"end":44,"text":"all AR coding bases and genomic regions that are highly informative in prostate cancer"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":30,"end":31,"text":"all"}]},"annotationSets":[{"rank":0,"score":24.62991170585983,"frameElements":[{"name":"Quantity","spans":[{"start":30,"end":31,"text":"all"}]}]}]},{"target":{"name":"Being_named","spans":[{"start":32,"end":33,"text":"coding"}]},"annotationSets":[{"rank":0,"score":17.45133732327637,"frameElements":[{"name":"Name","spans":[{"start":33,"end":34,"text":"bases"}]},{"name":"Entity","spans":[{"start":30,"end":32,"text":"all AR"}]}]}]},{"target":{"name":"Body_decoration","spans":[{"start":33,"end":34,"text":"bases"}]},"annotationSets":[{"rank":0,"score":28.449433955739956,"frameElements":[]}]},{"target":{"name":"Locale","spans":[{"start":36,"end":37,"text":"regions"}]},"annotationSets":[{"rank":0,"score":37.23915771618129,"frameElements":[{"name":"Locale","spans":[{"start":36,"end":37,"text":"regions"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":43,"end":44,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":35.05253134472619,"frameElements":[]}]}],"tokens":["To","determine","AR","gene","status","using","a","minimally","invasive","assay","that","could","have","broad","clinical","utility",",","we","developed","a","targeted","next-generation","sequencing","approach","amenable","to","plasma","DNA",",","covering","all","AR","coding","bases","and","genomic","regions","that","are","highly","informative","in","prostate","cancer","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":9,"end":10,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Communicate_categorization","spans":[{"start":11,"end":12,"text":"treated"}]},"annotationSets":[{"rank":0,"score":38.86425579802113,"frameElements":[{"name":"Speaker","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Item","spans":[{"start":12,"end":14,"text":"with abiraterone"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":15,"end":16,"text":"two"}]},"annotationSets":[{"rank":0,"score":30.429213838142118,"frameElements":[{"name":"Number","spans":[{"start":15,"end":16,"text":"two"}]},{"name":"Entity","spans":[{"start":16,"end":17,"text":"institutions"}]}]}]},{"target":{"name":"Institutions","spans":[{"start":16,"end":17,"text":"institutions"}]},"annotationSets":[{"rank":0,"score":19.42586122667598,"frameElements":[{"name":"Institution","spans":[{"start":16,"end":17,"text":"institutions"}]}]}]}],"tokens":["We","sequenced","274","plasma","samples","from","97","castration-resistant","prostate","cancer","patients","treated","with","abiraterone","at","two","institutions","."]}
{"frames":[{"target":{"name":"Control","spans":[{"start":1,"end":2,"text":"controlled"}]},"annotationSets":[{"rank":0,"score":16.69038950248925,"frameElements":[{"name":"Controlling_entity","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Mental_property","spans":[{"start":3,"end":4,"text":"normal"}]},"annotationSets":[{"rank":0,"score":19.1725483288976,"frameElements":[]}]},{"target":{"name":"Becoming_aware","spans":[{"start":10,"end":11,"text":"detected"}]},"annotationSets":[{"rank":0,"score":81.13714964023237,"frameElements":[{"name":"Cognizer","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Phenomenon","spans":[{"start":11,"end":17,"text":"a sufficiently high tumor DNA fraction"}]}]}]},{"target":{"name":"Degree","spans":[{"start":12,"end":13,"text":"sufficiently"}]},"annotationSets":[{"rank":0,"score":2.3472365728811657,"frameElements":[{"name":"Gradable_attribute","spans":[{"start":13,"end":14,"text":"high"}]}]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":13,"end":14,"text":"high"}]},"annotationSets":[{"rank":0,"score":19.891031069477272,"frameElements":[{"name":"Variable","spans":[{"start":14,"end":15,"text":"tumor"}]},{"name":"Degree","spans":[{"start":12,"end":13,"text":"sufficiently"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":14,"end":15,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]},{"target":{"name":"Duplication","spans":[{"start":20,"end":21,"text":"copy"}]},"annotationSets":[{"rank":0,"score":66.34096238890423,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":21,"end":22,"text":"number"}]},"annotationSets":[{"rank":0,"score":23.913514876636604,"frameElements":[{"name":"Quantity","spans":[{"start":21,"end":22,"text":"number"}]}]}]},{"target":{"name":"Political_locales","spans":[{"start":22,"end":23,"text":"state"}]},"annotationSets":[{"rank":0,"score":34.08154388717614,"frameElements":[{"name":"Locale","spans":[{"start":22,"end":23,"text":"state"}]}]}]}],"tokens":["We","controlled","for","normal","DNA","in","patients","'","circulation","and","detected","a","sufficiently","high","tumor","DNA","fraction","to","quantify","AR","copy","number","state","in","217","samples","-LRB-","80","patients","-RRB-","."]}
{"frames":[{"target":{"name":"Duplication","spans":[{"start":3,"end":4,"text":"copy"}]},"annotationSets":[{"rank":0,"score":70.12674752728066,"frameElements":[{"name":"Goal","spans":[{"start":4,"end":11,"text":"number gain and point mutations in plasma"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":4,"end":5,"text":"number"}]},"annotationSets":[{"rank":0,"score":24.810159608229526,"frameElements":[{"name":"Quantity","spans":[{"start":4,"end":5,"text":"number"}]},{"name":"Individuals","spans":[{"start":5,"end":11,"text":"gain and point mutations in plasma"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":5,"end":6,"text":"gain"}]},"annotationSets":[{"rank":0,"score":66.78430282644318,"frameElements":[{"name":"Project","spans":[{"start":4,"end":5,"text":"number"}]}]}]},{"target":{"name":"Locale","spans":[{"start":7,"end":8,"text":"point"}]},"annotationSets":[{"rank":0,"score":33.49631952269279,"frameElements":[{"name":"Locale","spans":[{"start":7,"end":8,"text":"point"}]}]}]},{"target":{"name":"Taking_sides","spans":[{"start":15,"end":16,"text":"supported"}]},"annotationSets":[{"rank":0,"score":48.94327917534733,"frameElements":[]}]},{"target":{"name":"Increment","spans":[{"start":16,"end":17,"text":"further"}]},"annotationSets":[{"rank":0,"score":15.958985512219995,"frameElements":[{"name":"Class","spans":[{"start":17,"end":27,"text":"by the enrichment of nonsynonymous versus synonymous mutations in AR"}]}]}]},{"target":{"name":"Processing_materials","spans":[{"start":19,"end":20,"text":"enrichment"}]},"annotationSets":[{"rank":0,"score":63.174555225903106,"frameElements":[]}]},{"target":{"name":"Word_relations","spans":[{"start":23,"end":24,"text":"synonymous"}]},"annotationSets":[{"rank":0,"score":15.159423360780679,"frameElements":[]}]},{"target":{"name":"Duplication","spans":[{"start":27,"end":28,"text":"copy"}]},"annotationSets":[{"rank":0,"score":64.89896314420925,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":28,"end":29,"text":"number"}]},"annotationSets":[{"rank":0,"score":24.280987746768126,"frameElements":[{"name":"Quantity","spans":[{"start":28,"end":29,"text":"number"}]}]}]},{"target":{"name":"Mental_property","spans":[{"start":29,"end":30,"text":"normal"}]},"annotationSets":[{"rank":0,"score":17.719338431520082,"frameElements":[{"name":"Behavior","spans":[{"start":30,"end":36,"text":"as opposed to AR gain samples"}]}]}]},{"target":{"name":"Taking_sides","spans":[{"start":31,"end":32,"text":"opposed"}]},"annotationSets":[{"rank":0,"score":61.107818343166656,"frameElements":[{"name":"Action","spans":[{"start":32,"end":36,"text":"to AR gain samples"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":34,"end":35,"text":"gain"}]},"annotationSets":[{"rank":0,"score":64.5845505369177,"frameElements":[{"name":"Project","spans":[{"start":35,"end":36,"text":"samples"}]}]}]}],"tokens":["Detection","of","AR","copy","number","gain","and","point","mutations","in","plasma","were","inversely","correlated",",","supported","further","by","the","enrichment","of","nonsynonymous","versus","synonymous","mutations","in","AR","copy","number","normal","as","opposed","to","AR","gain","samples","."]}
{"frames":[{"target":{"name":"Duplication","spans":[{"start":2,"end":3,"text":"copy"}]},"annotationSets":[{"rank":0,"score":75.50421026287904,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":3,"end":4,"text":"number"}]},"annotationSets":[{"rank":0,"score":24.92969176344289,"frameElements":[{"name":"Quantity","spans":[{"start":3,"end":4,"text":"number"}]}]}]},{"target":{"name":"Cure","spans":[{"start":8,"end":9,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":44.44858715031094,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":12,"end":13,"text":"no"}]},"annotationSets":[{"rank":0,"score":24.65189768342654,"frameElements":[{"name":"Quantity","spans":[{"start":12,"end":13,"text":"no"}]}]}]},{"target":{"name":"Evidence","spans":[{"start":16,"end":17,"text":"showed"}]},"annotationSets":[{"rank":0,"score":32.39362964309643,"frameElements":[{"name":"Proposition","spans":[{"start":17,"end":18,"text":"signal"}]}]}]},{"target":{"name":"Gesture","spans":[{"start":17,"end":18,"text":"signal"}]},"annotationSets":[{"rank":0,"score":32.41546745493567,"frameElements":[]}]},{"target":{"name":"Getting","spans":[{"start":19,"end":20,"text":"acquired"}]},"annotationSets":[{"rank":0,"score":51.58410339111826,"frameElements":[{"name":"Theme","spans":[{"start":20,"end":21,"text":"gain"}]}]}]},{"target":{"name":"Change_position_on_a_scale","spans":[{"start":20,"end":21,"text":"gain"}]},"annotationSets":[{"rank":0,"score":89.66454494905571,"frameElements":[]}]},{"target":{"name":"Statement","spans":[{"start":23,"end":24,"text":"observed"}]},"annotationSets":[{"rank":0,"score":116.25754252601351,"frameElements":[{"name":"Message","spans":[{"start":24,"end":42,"text":"emergence of T878A or L702H AR amino acid changes in 13 % of tumors at progression on abiraterone"}]},{"name":"Speaker","spans":[{"start":22,"end":23,"text":"we"}]}]}]},{"target":{"name":"Proliferating_in_number","spans":[{"start":24,"end":25,"text":"emergence"}]},"annotationSets":[{"rank":0,"score":59.736661062898655,"frameElements":[{"name":"Set","spans":[{"start":25,"end":33,"text":"of T878A or L702H AR amino acid changes"}]}]}]},{"target":{"name":"Intoxicants","spans":[{"start":31,"end":32,"text":"acid"}]},"annotationSets":[{"rank":0,"score":17.00148214779127,"frameElements":[{"name":"Intoxicant","spans":[{"start":31,"end":32,"text":"acid"}]}]}]},{"target":{"name":"Undergo_change","spans":[{"start":32,"end":33,"text":"changes"}]},"annotationSets":[{"rank":0,"score":58.02221192386038,"frameElements":[{"name":"Entity","spans":[{"start":31,"end":32,"text":"acid"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":37,"end":38,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":36.396816614044745,"frameElements":[]}]}],"tokens":["Whereas","AR","copy","number","was","unchanged","from","before","treatment","to","progression","and","no","mutant","AR","alleles","showed","signal","for","acquired","gain",",","we","observed","emergence","of","T878A","or","L702H","AR","amino","acid","changes","in","13","%","of","tumors","at","progression","on","abiraterone","."]}
{"frames":[{"target":{"name":"Change_position_on_a_scale","spans":[{"start":3,"end":4,"text":"gain"}]},"annotationSets":[{"rank":0,"score":98.42600071984909,"frameElements":[]}]},{"target":{"name":"Timespan","spans":[{"start":18,"end":19,"text":"times"}]},"annotationSets":[{"rank":0,"score":15.56947657420859,"frameElements":[]}]},{"target":{"name":"Likelihood","spans":[{"start":20,"end":21,"text":"likely"}]},"annotationSets":[{"rank":0,"score":33.74183679394563,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":17,"end":19,"text":"7.8 times"}]}]}]},{"target":{"name":"Being_obligated","spans":[{"start":22,"end":23,"text":"have"}]},"annotationSets":[{"rank":0,"score":14.863607123409833,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":26,"end":27,"text":"50"}]},"annotationSets":[{"rank":0,"score":21.899940339512927,"frameElements":[{"name":"Number","spans":[{"start":26,"end":27,"text":"50"}]},{"name":"Entity","spans":[{"start":28,"end":29,"text":">"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":30,"end":31,"text":"90"}]},"annotationSets":[{"rank":0,"score":24.77697191138083,"frameElements":[{"name":"Number","spans":[{"start":30,"end":31,"text":"90"}]}]}]},{"target":{"name":"Change_position_on_a_scale","spans":[{"start":32,"end":33,"text":"decline"}]},"annotationSets":[{"rank":0,"score":94.37830917971249,"frameElements":[{"name":"Item","spans":[{"start":30,"end":32,"text":"90 %"}]},{"name":"Attribute","spans":[{"start":33,"end":36,"text":"in prostate-specific antigen"}]}]}]},{"target":{"name":"Possession","spans":[{"start":43,"end":44,"text":"had"}]},"annotationSets":[{"rank":0,"score":33.64087886769067,"frameElements":[{"name":"Possession","spans":[{"start":44,"end":56,"text":"a significantly worse overall -LSB- hazard ratio -LRB- HR -RRB- , 7.33"}]}]}]},{"target":{"name":"Desirability","spans":[{"start":46,"end":47,"text":"worse"}]},"annotationSets":[{"rank":0,"score":30.14444154179689,"frameElements":[{"name":"Evaluee","spans":[{"start":50,"end":51,"text":"ratio"}]},{"name":"Degree","spans":[{"start":45,"end":46,"text":"significantly"}]}]}]},{"target":{"name":"Clothing","spans":[{"start":47,"end":48,"text":"overall"}]},"annotationSets":[{"rank":0,"score":35.66047233913659,"frameElements":[]}]},{"target":{"name":"Statement","spans":[{"start":49,"end":50,"text":"hazard"}]},"annotationSets":[{"rank":0,"score":93.47827306415245,"frameElements":[]}]},{"target":{"name":"Certainty","spans":[{"start":59,"end":60,"text":"confidence"}]},"annotationSets":[{"rank":0,"score":35.07148070857136,"frameElements":[{"name":"Cognizer","spans":[{"start":57,"end":59,"text":"95 %"}]}]}]},{"target":{"name":"Frequency","spans":[{"start":60,"end":61,"text":"interval"}]},"annotationSets":[{"rank":0,"score":31.16692912648417,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":73,"end":74,"text":"10"}]},"annotationSets":[{"rank":0,"score":23.163897218720706,"frameElements":[{"name":"Number","spans":[{"start":73,"end":74,"text":"10"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":97,"end":98,"text":"10"}]},"annotationSets":[{"rank":0,"score":23.163897218720706,"frameElements":[{"name":"Number","spans":[{"start":97,"end":98,"text":"10"}]}]}]},{"target":{"name":"Surviving","spans":[{"start":102,"end":103,"text":"survival"}]},"annotationSets":[{"rank":0,"score":14.121729648906221,"frameElements":[]}]}],"tokens":["Patients","with","AR","gain","or","T878A","or","L702H","before","abiraterone","-LRB-","45","%","-RRB-","were","4.9","and","7.8","times","less","likely","to","have","a",">","=","50","or",">","=","90","%","decline","in","prostate-specific","antigen","-LRB-","PSA","-RRB-",",","respectively",",","and","had","a","significantly","worse","overall","-LSB-","hazard","ratio","-LRB-","HR","-RRB-",",","7.33",";","95","%","confidence","interval","-LRB-","CI","-RRB-",",","3.51","to","15.34",";","P","=","1.3","x","10","-LRB-","-9","-RRB-","-RRB-","and","progression-free","-LRB-","HR",",","3.73",";","95","%","CI",",","2.17","to","6.41",";","P","=","5.6","x","10","-LRB-","-7","-RRB-","-RRB-","survival","."]}
{"frames":[{"target":{"name":"Assessing","spans":[{"start":0,"end":1,"text":"Evaluation"}]},"annotationSets":[{"rank":0,"score":87.8675355493648,"frameElements":[{"name":"Phenomenon","spans":[{"start":1,"end":7,"text":"of plasma AR by next-generation sequencing"}]}]}]},{"target":{"name":"Capability","spans":[{"start":7,"end":8,"text":"could"}]},"annotationSets":[{"rank":0,"score":41.39645568958401,"frameElements":[{"name":"Event","spans":[{"start":8,"end":9,"text":"identify"}]},{"name":"Entity","spans":[{"start":0,"end":7,"text":"Evaluation of plasma AR by next-generation sequencing"}]}]}]},{"target":{"name":"Verification","spans":[{"start":8,"end":9,"text":"identify"}]},"annotationSets":[{"rank":0,"score":63.398444452308226,"frameElements":[{"name":"Unconfirmed_content","spans":[{"start":0,"end":7,"text":"Evaluation of plasma AR by next-generation sequencing"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":9,"end":10,"text":"cancers"}]},"annotationSets":[{"rank":0,"score":40.33515201043533,"frameElements":[]}]},{"target":{"name":"First_rank","spans":[{"start":11,"end":12,"text":"primary"}]},"annotationSets":[{"rank":0,"score":12.99568493151974,"frameElements":[{"name":"Item","spans":[{"start":12,"end":13,"text":"resistance"}]}]}]}],"tokens":["Evaluation","of","plasma","AR","by","next-generation","sequencing","could","identify","cancers","with","primary","resistance","to","abiraterone","."]}
